The genetic alterations and signalling pathways involved during the formation and progression of CRC include the Wnt signalling pathway, RAS/mitogen-activated protein kinase (MAPK), transforming growth factor beta (TGFβ) and TP53 signalling [2]. This evidence concerns the gene TGFB1 and colorectal carcinoma.